• Source: Lepodisiran

    • Lepodisiran (LY3819469) is a small interfering RNA that was developed to reduce lipoprotein(a) in people at risk of cardiovascular disease. It was developed by Eli Lilly and Company.


    References

Kata Kunci Pencarian: